BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 9042240)

  • 1. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.
    Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM
    Anticancer Res; 1996; 16(6B):3673-7. PubMed ID: 9042240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
    Zhai Y; Lu ZJ
    Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ; Lin HH; Xu QT; Wang MW
    Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice.
    Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N
    Anticancer Res; 2003; 23(3B):2405-11. PubMed ID: 12894521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of thalidomide and paclitaxel on hepatocellular carcinoma in nude mice.
    Zhang ZL; Liu ZS; Sun Q
    Chin Med J (Engl); 2005 Oct; 118(20):1688-94. PubMed ID: 16313753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
    Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.
    Lum CT; Huo L; Sun RW; Li M; Kung HF; Che CM; Lin MC
    Acta Oncol; 2011 Jun; 50(5):719-26. PubMed ID: 21110776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.
    Maekawa R; Maki H; Yoshida H; Hojo K; Tanaka H; Wada T; Uchida N; Takeda Y; Kasai H; Okamoto H; Tsuzuki H; Kambayashi Y; Watanabe F; Kawada K; Toda K; Ohtani M; Sugita K; Yoshioka T
    Cancer Res; 1999 Mar; 59(6):1231-5. PubMed ID: 10096553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
    Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
    Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.